In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Forest Laboratories, Inc.

http://www.frx.com

Latest From Forest Laboratories, Inc.

Finance Watch: One Week Of IPOs Total $818.2m

Relay raises $400m to kick off July’s second big week of US initial public offerings. Also, Ocumension and Immunotech launch Hong Kong IPOs, Amgen invests $421m in BeiGene’s $2.08bn offering, Cytokinetics gets up to $400m in deal and investment funding, and Imvax closes $111m series C round.

Financing Business Strategies

Lessons From COVID-19: How Pharma Supply Chains Must Evolve Before Next Disaster

Experts describe the agile, localized supply chains that will emerge, only perhaps to be forgotten just-in-time for the next crisis.

Coronavirus COVID-19 Distribution

How Some Manufacturers Are Navigating COVID-19 Pharma Supply Chain Challenges

Gilead, Vetter, Lonza and academic experts share what they’re focusing on to keep producing drugs during the pandemic.

Manufacturing Quality

Daraprim Drug Pricing Suit Against Shkreli And Vyera May Signal Future FTC Actions

In joint complaint, the FTC and New York Attorney General allege scheme to block generic Daraprim and maintain exorbitant list price; they cite hundreds of emails the incarcerated Shkreli has exchanged with co-defendant in last six months.

Legal Issues Pricing Strategies
See All

Company Information

  • Other Names / Subsidiaries
    • Aptalis Pharma Inc. (Axcan Pharma, Inc.
    • Eurand N.V.
    • Mpex Pharmaceuticals, Inc.)
    • Cerexa, Inc.
    • Clinical Data, Inc.
UsernamePublicRestriction

Register